Experimental model of focal sclerosis. II. Correlation with immunopathologic changes, macromolecular kinetics, and polyanion loss.
D000818:Animals; D004195:Disease Models, Animal; D005169:Factor VIII / Q000378:metabolism; D005337:Fibrin / Q000378:metabolism; D005921:Glomerulonephritis / Q000503:physiopathology*; D005923:Glomerulosclerosis, Focal Segmental / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007678:Kidney Glomerulus / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008297:Male; D009392:Nephrectomy; D011507:Proteinuria / Q000139:chemically induced; D011692:Puromycin Aminonucleoside / Q000009:adverse effects; D051381:Rats; D012795:Sialoglycoproteins / Q000378:metabolism
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012795:Sialoglycoproteins; D011692:Puromycin Aminonucleoside; D005169:Factor VIII; D005337:Fibrin